Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer

The prediction of the response to Bacillus Calmette-Guerin (BCG) can help identify non-muscle-invasive bladder cancer (NMIBC) patients that may be better served with alternative therapy. Several cytokine profiles present promising results, but they are difficult to use in clinical practice. In this...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncoimmunology
Main Authors: Zhong, Wenlong, Wang, Bo, Yu, Hao, Lin, Jianxun, Xia, Kun, Hou, Weibin, Yang, Meihua, Chen, Junyu, Yang, Meng, Wang, Xiaofei, Huang, Jian, Lin, Tianxin
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458591/
https://ncbi.nlm.nih.gov/pubmed/32923138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1776060
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki